Centurion Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$875K Sell
2,417
-343
-12% -$117K 0.21% 108
2026
Q1
$971K Sell
2,760
-296
-10% -$106K 0.22% 93
2025
Q4
$1M Sell
3,056
-147
-5% -$46.6K 0.22% 87
2025
Q3
$904K Buy
3,203
+898
+39% +$260K 0.21% 90
2025
Q2
$644K Sell
2,305
-358
-13% -$101K 0.18% 99
2025
Q1
$694K Hold
2,663
0.22% 82
2024
Q4
$694K Buy
2,663
+163
+7% +$48.4K 0.22% 82
2024
Q3
$805K Buy
+2,500
New +$818K 0.26% 72
2024
Q1
$445K Sell
1,564
-13
-0.8% -$3.8K 0.18% 93
2023
Q4
$454K Buy
1,577
+12
+0.8% +$3.27K 0.19% 87
2023
Q3
$421K Buy
1,565
+3
+0.2% +$749 0.21% 83
2023
Q2
$347K Sell
1,562
-77
-5% -$17.9K 0.17% 98
2023
Q1
$396K Sell
1,639
-41
-2% -$10.1K 0.2% 89
2022
Q4
$441K Buy
+1,680
New +$450K 0.25% 82

Other funds holding AMGN

Centurion Wealth Management's AMGN Position: Q2 2026 in Review

Centurion Wealth Management reduced its Amgen (AMGN) stake by 12% in Q2 2026, selling an estimated $117K and leaving 2,417 shares worth $875K. The position accounts for 0.21% of the portfolio, ranked #108.

Centurion Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1M in Q4 2025. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Centurion Wealth Management held 2,417 shares of Amgen worth $875K as of Q2 2026.
  • Centurion Wealth Management sold 343 Amgen shares in Q2 2026, an estimated $117K.
  • Amgen made up 0.21% of Centurion Wealth Management's portfolio in Q2 2026, its #108 holding.
  • Centurion Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Centurion Wealth Management's Amgen position peaked at $1M in Q4 2025.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.